INVEGA SUSTENNA (Janssen Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the INVEGA SUSTENNA drug offered from Janssen Pharmaceuticals, Inc.. This Atypical Antipsychotic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Janssen Pharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | paliperidone palmitate |
SUBSTANCE NAME: | PALIPERIDONE PALMITATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Atypical Antipsychotic [EPC] |
ROUTE: | INTRAMUSCULAR |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2009-07-31 |
END MARKETING DATE: | 0000-00-00 |
INVEGA SUSTENNA HUMAN PRESCRIPTION DRUG Details:
Item Description | INVEGA SUSTENNA from Janssen Pharmaceuticals, Inc. |
LABELER NAME: | Janssen Pharmaceuticals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 39(mg/.25mL) |
START MARKETING DATE: | 2009-07-31 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 50458-560_b6eae897-f1a1-4d14-a0fa-af5577c7e36d |
PRODUCT NDC: | 50458-560 |
APPLICATION NUMBER: | NDA022264 |
Other PALIPERIDONE PALMITATE Pharmaceutical Manufacturers / Labelers: